Alembic Pharmaceuticals Tag - Passionate In Marketing

Generate Character Variations Using an AI Image Generator Rapidly

December 8, 2025

Alldigi Tech, a Digitide Company, Recognized as Major Contender & Star Performer in Everest Group’s Multi-Country Payroll (MCP) PEAK Matrix® Assessment 2025

December 8, 2025

BirlaNu’s first AI-driven brand film ‘Every Home is a Castle’ reimagines the meaning of dream homes

December 8, 2025

IIM Visakhapatnam Partners with Imarticus School of Finance & Business (ISFB) to Offer First-of-its-Kind Academic Experience for Undergraduate and Postgraduate Students

December 2, 2025

NIESBUD Hosts High-Level Delegation from South Sudan for International Training Programme on Strengthening PPP Models in the TVET Ecosystem

December 5, 2025

HMD Doubles Down on Affordable Featurephones Segment, Launches HMD 100 & HMD 101 to Capture Volume Leadership Crown

December 6, 2025

ABOUT US

Passionate in Marketing is promoted by i-miRa Knowledge Solutions, a company founded in 2010 to foster various business units dedicated to creating, disseminating, and managing knowledge-based products, services, and solutions. These offerings cater to corporate entities, startups, and academic institutions alike.

Contact : [email protected]

Alldigi Tech, a Digitide Company, Recognized as Major Contender & Star Performer in Everest Group’s Multi-Country Payroll (MCP) PEAK Matrix® Assessment 2025

9shines Label Creates a New Nightwear Category in India With 500+ Styles, Premium Craft & Modern Comfort

Flam Appoints Rachit Jain as Head of GTM Strategy (Global) to Accelerate International Expansion

Nalanda Literature Festival Partners with Nava Nalanda Mahavihara to Celebrate the Global ‘Nalanda Spirit’

Tag: Alembic Pharmaceuticals

Alembic Pharmaceuticals and Amlan International launch MinerTox-Z and MinerTox-A

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbamazepine Extended-Release Tablets.

Alembic Pharmaceuticals acquires Utility Therapeutics for $12 million to strengthen U.S. footprint

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg

Alembic Pharmaceuticals receives USFDA Final Approval for Dabigatran Etexilate Capsules, 110 mg.

Alembic Pharmaceuticals announces USFDA Tentative Approval for Ivosidenib Tablets 250 mg

Alembic Pharmaceuticals announces USFDA Approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and Tentative approval for Dabigatran Etexilate Capsules, 110 mg

Alembic Pharmaceuticals Receives 5 USFDA Product Approvals in Q1FY25

Alembic Pharmaceuticals Limited Receives Establishment Inspection Report (EIR) for its Oncology Formulation Facility at Panelav

EDITOR PICKS

Generate Character Variations Using an AI Image Generator Rapidly

Alldigi Tech, a Digitide Company, Recognized as Major Contender & Star Performer in Everest Group’s Multi-Country Payroll (MCP) PEAK Matrix® Assessment 2025

BirlaNu’s first AI-driven brand film ‘Every Home is a Castle’ reimagines the meaning of dream homes

POPULAR POSTS

IIM Visakhapatnam Partners with Imarticus School of Finance & Business (ISFB) to Offer First-of-its-Kind Academic Experience for Undergraduate and Postgraduate Students

NIESBUD Hosts High-Level Delegation from South Sudan for International Training Programme on Strengthening PPP Models in the TVET Ecosystem

HMD Doubles Down on Affordable Featurephones Segment, Launches HMD 100 & HMD 101 to Capture Volume Leadership Crown

POPULAR CATEGORY

ABOUT US

FOLLOW US